These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21175365)

  • 1. Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models.
    Goswami D; Khuroo AH; Gurule S; Kumar A; Monif T
    Bioanalysis; 2011 Jan; 3(1):31-43. PubMed ID: 21175365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Pharm Biomed Anal; 2008 Jul; 47(3):603-11. PubMed ID: 18387768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-mass spectrometry method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study.
    Wei Z; Bing-Ren X; Cai-Yun W
    Biomed Chromatogr; 2007 Mar; 21(3):266-72. PubMed ID: 17230450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Pharm Biomed Anal; 2009 Feb; 49(2):354-66. PubMed ID: 19062215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
    Qin F; Li N; Qin T; Zhang Y; Li F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):689-94. PubMed ID: 20133212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?
    Kandhwal K; Dey S; Nazarudheen S; Reyar S; Mishra S; Thudi NR; Khuroo AH; Monif T
    Chirality; 2011 Nov; 23(10):948-54. PubMed ID: 21953854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employing atmospheric pressure photoionization in liquid chromatography/tandem mass spectrometry to minimize ion suppression and matrix effects for the quantification of venlafaxine and O-desmethylvenlafaxine.
    Theron HB; van der Merwe MJ; Swart KJ; van der Westhuizen JH
    Rapid Commun Mass Spectrom; 2007; 21(10):1680-6. PubMed ID: 17465011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for plasma citrate determination by reversed-phase high-performance liquid chromatography after ultrafiltration extraction: an example for bioequivalence evaluation of a medicinal endogenous substance.
    Gu Y; Wang GJ; Sun JG; Zhang XY; Sai Y
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):513-20. PubMed ID: 18985179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
    Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI
    J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the bioequivalence of two carbamazepine sustained-release formulations in healthy subjects.
    Schulz HU; Düsing R; Lührmann B; Frercks HJ
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):410-4. PubMed ID: 1446959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability/bioequivalence of modified release drug delivery systems: which pharmacokinetic parameters to determine, single or multiple dose studies, pretests, conditions and other aspects.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1992; 14(6):469-82. PubMed ID: 1469957
    [No Abstract]   [Full Text] [Related]  

  • 19. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach for outliers in a bioavailability/bioequivalence study.
    Liao JJ
    J Biopharm Stat; 2007; 17(3):393-405. PubMed ID: 17479389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.